Skip to main content

Table 4 Echocardiographic parameters in females 16 weeks after induction of Ampkα2 deletion by tamoxifen injection

From: Spatiotemporal AMPKα2 deletion in mice induces cardiac dysfunction, fibrosis and cardiolipin remodeling associated with mitochondrial dysfunction in males only

Echocardiographic parameters

Ampkα2f/f n = 7

Ampkα2ciKO n = 6

HR (beats/min)

384 ± 30

447 ± 35

IVSd (mm)

0.97 ± 0.12

0.99 ± 0.09

IVSs (mm)

1.49 ± 0.12

1.56 ± 0.15

LVIDd (mm)

2.76 ± 0.21

2.55 ± 0.16

LVIDs (mm)

1.50 ± 0.16

1.30 ± 0.12

LVPWd (mm)

1.10 ± 0.07

1.03 ± 0.03

LVPWs (mm)

1.48 ± 0.08

1.46 ± 0.10

EDV (ml)

0.07 ± 0.01

0.05 ± 0.01

ESV (ml)

0.12 ± 0.02

0.09 ± 0.01

EF (%)

81.1 ± 4.4

82.4 ± 0.4

SV (ml)

0.05 ± 0.01

0.05 ± 0.01

FS (%)

45.4 ± 4.7

47.1 ± 1.0

CO (ml/min)

18.4 ± 4.3

21.2 ± 3.6

  1. HR, heart rate; IVSd, interventricular septal thickness at end-diastole; IVSs, interventricular septal thickness at end-systole; LVIDd, left ventricular internal dimension at end-diastole; LVIDs, left ventricular internal dimension at end-systole; LVWPd, left ventricular posterior wall thickness at end-diastole; LVWPs, left ventricular posterior wall thickness at end-systole; EDV, end-diastolic volume; ESV, end-systolic volume; EF, left ventricular ejection fraction; SV, stroke volume; FS, left ventricular fractional shortening; CO, cardiac output